Collegeville, PA, United States of America

Yiqian Lian

This inventor holds 6 USPTO granted patents and 1 published patent application and 4 EPO patents. Top assignee: Glaxosmithkline Intellectual Property Development Limited. Active years: 2017-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yiqian Lian. Retrieved from https://idiyas.com/inventor/yiqian-lian

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 50.0

 

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 38(Granted Patents)


Company Filing History:


Years Active: 2017-2024

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Yiqian Lian

Introduction

Yiqian Lian is a prominent inventor based in Collegeville, PA, known for his significant contributions to the field of protein modulation. With a total of six patents to his name, Lian has made strides in developing compounds that have the potential to impact various therapeutic areas.

Latest Patents

Among his latest patents is a groundbreaking work titled "Heterocyclic amides useful as protein modulators." This patent discloses compounds that are designed to modulate protein functions, showcasing Lian's innovative approach to addressing complex biological challenges.

Career Highlights

Lian is currently associated with GlaxoSmithKline Intellectual Property Development Limited, where he continues to push the boundaries of scientific research and innovation. His work at this esteemed company has allowed him to collaborate with other talented professionals in the field.

Collaborations

Some of Lian's notable coworkers include Jerry Leroy Adams and Adam Kenneth Charnley, who contribute to the collaborative environment that fosters innovation and creativity in their projects.

Conclusion

Yiqian Lian's contributions to the field of protein modulation through his patents and collaborations highlight his role as a key innovator in the industry. His work continues to pave the way for advancements in therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…